INSIDE CHINA: Honeymoon or harsh times in China when Medtronic and Covidien merge?
This article was originally published in Clinica
Executive Summary
Michael Alper of NeuvoMedica discusses the implications – good and bad – of the pending Medtronic and Covidien merger on the companies’ operations in China and on other players in that market